- Home
- MTNB vs GURE Comparison
MTNB vs GURE Comparison
Compare MTNB & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- GURE
- Stock Information
- Founded
- MTNB 2013
- GURE 2006
- Country
- MTNB United States
- GURE China
- Employees
- MTNB N/A
- GURE N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- GURE Major Chemicals
- Sector
- MTNB Health Care
- GURE Industrials
- Exchange
- MTNB Nasdaq
- GURE Nasdaq
- Market Cap
- MTNB 7.9M
- GURE 9.5M
- IPO Year
- MTNB N/A
- GURE 1992
- Fundamental
- Price
- MTNB $1.68
- GURE $0.75
- Analyst Decision
- MTNB Hold
- GURE
- Analyst Count
- MTNB 1
- GURE 0
- Target Price
- MTNB N/A
- GURE N/A
- AVG Volume (30 Days)
- MTNB 1.4M
- GURE 60.5K
- Earning Date
- MTNB 08-14-2025
- GURE 08-13-2025
- Dividend Yield
- MTNB N/A
- GURE N/A
- EPS Growth
- MTNB N/A
- GURE N/A
- EPS
- MTNB N/A
- GURE N/A
- Revenue
- MTNB N/A
- GURE $13,919,011.00
- Revenue This Year
- MTNB N/A
- GURE N/A
- Revenue Next Year
- MTNB N/A
- GURE N/A
- P/E Ratio
- MTNB N/A
- GURE N/A
- Revenue Growth
- MTNB N/A
- GURE N/A
- 52 Week Low
- MTNB $0.47
- GURE $0.50
- 52 Week High
- MTNB $4.25
- GURE $1.47
- Technical
- Relative Strength Index (RSI)
- MTNB 52.06
- GURE 60.43
- Support Level
- MTNB $1.64
- GURE $0.69
- Resistance Level
- MTNB $1.90
- GURE $0.75
- Average True Range (ATR)
- MTNB 0.24
- GURE 0.07
- MACD
- MTNB -0.05
- GURE 0.00
- Stochastic Oscillator
- MTNB 38.38
- GURE 56.25
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.